Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders

Bocharov1 A.V.; Kondakova2 V.E.; Tuleninov1 E.S.

doi:https://doi.org/

Bocharov1 A.V.

Sankt-Peterburgskaia meditsinskaia akademiia;
Sankt-Peterburgskaia gorodskaia psikhiatricheskaia bol'nitsa #6

Kondakova2 V.E.

Tuleninov1 E.S.

Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders

Authors:

Bocharov1 A.V., Kondakova2 V.E., Tuleninov1 E.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(6): 25‑31

Read: 22986 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Bocharov1 AV, Kondakova2 VE, Tuleninov1 ES. Efficasy and safety of the use of risperidone (rispoluxe) in demented patients with psychotic and behavioural disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(6):25‑31. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Non-invasive biomarkers for early diagnosis of Alzheimer’s disease in bodily fluids. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):8-16

Nutritional care for patients with neurodegenerative diseases in the outpatient practice of a neurologist. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):76-83

The experience of diagnosing Alzheimer’s disease based on the study of cerebrospinal fluid biomarkers. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):91-97

Population models for the general and primary incidence of borderline mental disorders in the Russian Federation in 1992—2022. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):113-121

Comparative study of cognitive impairment in subgroups of bipolar affective disorder types I and II, occurring with and without psychotic symptoms. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):7-11

Cognitive functions assessment of elderly patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):46-50

Relationship between stroke-associated pneumonia and long-term outcomes of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):57-61

Potential of animal-derived neuropeptides in complex therapy of diabetic neuropathy in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):83-87

Epidemiology of M. genitalium infection. What is known?. Russian Journal of Clinical Dermatology and Venereology. 2025;(2):143-152

Study of the levocarnitine efficacy for the treatment of moderate cognitive impairment in patients with hypertension. Russian Journal of Preventive Medicine. 2025;(4):45-50

Abstract:

Based on the comparison of international and Russian studies, authors present a review on the epidemiology, clinical features, diagnosis and treatment of psychotic and behavioral disorders in patients with dementia. Results of the own study on the efficacy of risperidone (rispolux) in dosage 102 mg daily in patients with dementia with psychotic and behavioral disorders are presented. It has been shown that rispolux reduces psychotic and behavioral disorders, improves cognitive functions. It is well-tolerated and rather safe for elderly patients.

Keywords:

dementia

cognitive disorders

psychotic disorders

behavioral disorders

prevalence